Resverlogix Corp (RVXCF)
0.037
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Resverlogix Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
April 30, 2010 | 0.00 |
January 31, 2010 | 0.00 |
October 31, 2009 | 1.002 |
July 31, 2009 | 0.5433 |
April 30, 2009 | 0.4163 |
January 31, 2009 | -1.092 |
October 31, 2008 | -13.50 |
July 31, 2008 | 4.778 |
April 30, 2008 | 2.224 |
January 31, 2008 | 1.279 |
October 31, 2007 | 1.421 |
July 31, 2007 | 3.55 |
April 30, 2007 | -13.00 |
January 31, 2007 | 4.074 |
October 31, 2006 | 0.00 |
July 31, 2006 | 0.00 |
April 30, 2006 | 0.00 |
Date | Value |
---|---|
January 31, 2006 | 0.0009 |
October 31, 2005 | 0.0016 |
July 31, 2005 | 0.0022 |
April 30, 2005 | 0.0027 |
January 31, 2005 | 0.0026 |
October 31, 2004 | 0.0095 |
July 31, 2004 | 0.01 |
April 30, 2004 | 0.0084 |
January 31, 2004 | 0.0119 |
October 31, 2003 | 0.0297 |
July 31, 2003 | 0.0268 |
April 30, 2003 | 0.0152 |
January 31, 2003 | 0.00 |
October 31, 2002 | 0.00 |
July 31, 2002 | 0.00 |
April 30, 2002 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
CeCors Inc | -- |
Venus Concept Inc | -3.411 |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 0.00 |
Edesa Biotech Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 6.519M |
Total Liabilities (Quarterly) | 80.99M |
Shareholders Equity (Quarterly) | -74.47M |